BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 26261151)

  • 21. [Neuro-Behçet's disease. Case description and review of the literature].
    Colombo A; Valenti G
    Riv Neurol; 1982; 52(2):97-107. PubMed ID: 7048499
    [No Abstract]   [Full Text] [Related]  

  • 22. Scleromyxedema with histology resembling granuloma annulare.
    Mullangi S; Granter SR; Laubach JP; Lipworth AD
    Dermatol Online J; 2014 Dec; 21(3):. PubMed ID: 25780962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Scleromyxedema with neurological symptoms: successful treatment with immunoglobulins].
    Manríquez J; Berroeta-Mauriziano D; Andino-Navarrete R; Vera-Kellet C
    Med Clin (Barc); 2015 Jan; 144(1):47-8. PubMed ID: 24656121
    [No Abstract]   [Full Text] [Related]  

  • 24. Atypical scleromyxedema with prominent nodular lesions associated with immune thrombocytopenia: an unusual presentation.
    Lopez-Lerma I; Fernandez-Codina A; Hilari H; Ferrer B; Selva-O'Callaghan A; Garcia-Patos V
    J Am Acad Dermatol; 2014 Oct; 71(4):e158-9. PubMed ID: 25219747
    [No Abstract]   [Full Text] [Related]  

  • 25. Scleromyxedema with dermato-neuro syndrome.
    Gonzalez J; Palangio M; Schwartz J; Klainer AS; Bisaccia E
    J Am Acad Dermatol; 2000 May; 42(5 Pt 2):927-8. PubMed ID: 10767707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiomyopathy in scleromyxedema: report of a fatal case.
    De Simone C; Castriota M; Carbone A; Marini Bettolo P; Pieroni M; Rongioletti F
    Eur J Dermatol; 2010; 20(6):852-3. PubMed ID: 20977988
    [No Abstract]   [Full Text] [Related]  

  • 27. Papular mucinosis associated with monoclonal gammopathy of unknown significance.
    Thatte SS; Dongre AM; Chikhalkar SB; Khopkar US
    Indian J Dermatol Venereol Leprol; 2015; 81(2):213-4. PubMed ID: 25751354
    [No Abstract]   [Full Text] [Related]  

  • 28. Scleromyxedema with an interstitial granulomatous-like pattern: a rare histologic variant mimicking granuloma annulare.
    Rongioletti F; Cozzani E; Parodi A
    J Cutan Pathol; 2010 Oct; 37(10):1084-7. PubMed ID: 19638067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SARS-CoV-2: A potential trigger of dermato-neuro syndrome in a patient with scleromyxedema.
    Fritz M; Tinker D; Wessel AW; Morris GM; Goldenberg L; Fesler M; Rukmangadachar L; Hurley MY
    JAAD Case Rep; 2021 Dec; 18():99-102. PubMed ID: 34778497
    [No Abstract]   [Full Text] [Related]  

  • 30. Scleromyxedema.
    Chatterjee S; Fernandez AP
    N Engl J Med; 2023 Nov; 389(21):1992. PubMed ID: 37991858
    [No Abstract]   [Full Text] [Related]  

  • 31. Dermato-neuro Syndrome after COVID-19 Vaccination in a Patient with Scleromyxoedema Previously Controlled with Bortezomib and Intravenous Immunoglobulins.
    Gallo R; Trave I; Cotzia E; Russo R; Parodi A
    Acta Derm Venereol; 2022 Dec; 102():adv00836. PubMed ID: 36511333
    [No Abstract]   [Full Text] [Related]  

  • 32. Scleromyxedema and Hyperphosphatemia: Causal Relationship or Coincidence?
    Mousavi S; Masoumi M; Shakiba S
    J Clin Rheumatol; 2021 Aug; 27(5):e160-e161. PubMed ID: 32028300
    [No Abstract]   [Full Text] [Related]  

  • 33. [HaNDL syndrome and Hashimoto encephalopathy. Reply].
    Martín-Balbuena S; Arpa-Gutiérrez FJ
    Rev Neurol; 2009 Jan 16-31; 48(2):112. PubMed ID: 19173213
    [No Abstract]   [Full Text] [Related]  

  • 34. Managing scleromyxedema with intravenous immunoglobulin: acute worsening of scleromyxedema with biclonal gammopathy.
    Manousaridis I; Loeser C; Goerdt S; Hassel JC
    Acta Dermatovenerol Alp Pannonica Adriat; 2010 Dec; 19(4):15-9. PubMed ID: 21390475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Scleromyxedema vs scleredema: a diagnostic challenge.
    Conde Fernandes I; Sanches M; Velho G; Lobo I; Alves R; Selores M
    Eur J Dermatol; 2011; 21(5):822-3. PubMed ID: 21771713
    [No Abstract]   [Full Text] [Related]  

  • 36. Acute perfusion MR imaging in a HaNDL-like syndrome.
    Vallet AE; Desestret V; Tahon F; Cho TH; Nighoghossian N
    Cerebrovasc Dis; 2010; 29(1):98-100. PubMed ID: 19923817
    [No Abstract]   [Full Text] [Related]  

  • 37. Scleromyxedema.
    Bogner RR; Wetter DA; Dingli D
    Intern Med; 2014; 53(21):2561-2. PubMed ID: 25366027
    [No Abstract]   [Full Text] [Related]  

  • 38. Dössekker's atypical tuberous myxoedema, a rare variant of scleromyxoedema.
    Ali FR; Ho P; Chaudhry IH; Motta L; Chalmers RJ
    Lancet; 2015 May; 385(9983):2222. PubMed ID: 26068270
    [No Abstract]   [Full Text] [Related]  

  • 39. Scleroderma renal crisis-like acute renal failure associated with mucopolysaccharide accumulation in renal vessels in a patient with scleromyxedema.
    Lee YH; Sahu J; O'Brien MS; D'Agati VD; Jimenez SA
    J Clin Rheumatol; 2011 Sep; 17(6):318-22. PubMed ID: 21869708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Scleromyxedema: a multicenter study of characteristics, comorbidities, course, and therapy in 30 patients.
    Rongioletti F; Merlo G; Cinotti E; Fausti V; Cozzani E; Cribier B; Metze D; Calonje E; Kanitakis J; Kempf W; Stefanato CM; Marinho E; Parodi A
    J Am Acad Dermatol; 2013 Jul; 69(1):66-72. PubMed ID: 23453242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.